utjecaj koronavirusa na farmaceutiku Archives - Grabancijaš

<img width="145" height="90" alt="Grabancijaš" decoding="async" data-src="https://grabancijas.com/wp-content/uploads/2019/03/Grab_Footer.jpg" class="custom-logo lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="145" height="90" src="https://grabancijas.com/wp-content/uploads/2019/03/Grab_Footer.jpg" class="custom-logo" alt="Grabancijaš" decoding="async" />

portal s integritetom, neovisnošću i slobodom od pristranosti

<img width="145" height="90" alt="Grabancijaš" decoding="async" data-src="https://grabancijas.com/wp-content/uploads/2019/03/Grab_Footer.jpg" class="custom-logo lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="145" height="90" src="https://grabancijas.com/wp-content/uploads/2019/03/Grab_Footer.jpg" class="custom-logo" alt="Grabancijaš" decoding="async" />

29/10/20201238

Gilead srezao izglede za prodaju remdesivira, dionica posrnula

Gilead Sciences u srijedu je javio o kvartalnom rastu prihoda za 17%, ali je udjel od remdesivira, u Americi zasad jedinog odobrenog lijeka za bolest

VIŠE